I decided to join your pain, I know i've been critical of the financing arrangements but with the pipeline of trial data and POC due in 2015 i've bought a few prior to results because the market now has the appetite to push biotechs really hard on any positive info. I know there might be a bit more pain because someone is still selling, evident by any buy parcel of 100k plus units getting hit straight away. I'm most interested in their work re asthma because this market is both huge and stale of innovation and any positive momentum would bring both significant interest and investment. Interestingly, there is going to be a new listing called Paradigm Bio. (PAR) and they are also in process of conducting trials for the treatment of asthma so Invion needs to keeps the wheels turning to be ahead of the competition.
IVX Price at posting:
4.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)